Management of advanced renal cell carcinoma remains a persistent clinical ... tumor biology at the molecular level and perhaps predict prognosis. Pathways involved in angiogenesis (VEGF expression ...

Cystic renal cell carcinoma is a predominantly cystic lesion with a small solid component (25% or less). Renal cell carcinoma usually presents as a solid mass; however, in 10–22% of cases ...

Neoadjuvant therapy for high-risk renal cell carcinoma (RCC) may offer a survival advantage over adjuvant therapy, according to data presented at the 2024 annual meeting of the Society of Urologic ...

An estimated 81,000 people in the US are diagnosed with kidney cancer each year. Despite the disease having a good prognosis ...

Figure 1: Characterization of the hybrid cell vaccine. The hybrid cell vaccination was well tolerated by all patients. There were no serious adverse effects or any clinical signs of autoimmune ...

Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.

Jaime Merchan, MD, discusses the efficacy results observed in the LITESPARK-013 trial of belzutifan in patients with advanced clear cell renal cell carcinoma.